Jagsonpal Pharmaceuticals Ltd (JGSN)

Currency in INR
254.20
+1.77(+0.70%)
Closed·
JGSN Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
JGSN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
248.86257.76
52 wk Range
133.60328.04
Key Statistics
Bid/Ask
253.40 / 254.20
Prev. Close
252.43
Open
252.95
Day's Range
248.86-257.76
52 wk Range
133.6-328.04
Volume
225.71K
Average Volume (3m)
237.15K
1-Year Change
71.42%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
JGSN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Jagsonpal Pharmaceuticals Ltd Company Profile

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. It serves health care professionals and government institutions. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in New Delhi, India.

Employees
1025
Market
India

Compare JGSN to Peers and Sector

Metrics to compare
JGSN
Peers
Sector
Relationship
P/E Ratio
30.1x31.5x−0.5x
PEG Ratio
0.210.310.00
Price/Book
6.9x3.6x2.6x
Price / LTM Sales
6.2x3.6x3.2x
Upside (Analyst Target)
-1.1%43.8%
Fair Value Upside
Unlock−0.4%5.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8.26%
Dividend Yield
0.79%
Industry Median 0.74%
Annualised payout
2.00
Paid annually
5-Years Growth
+65.72%
Growth Streak

Earnings

Latest Release
May 06, 2025
EPS / Forecast
0.98 / --
Revenue / Forecast
613.30M / --
EPS Revisions
Last 90 days

JGSN Income Statement

People Also Watch

394.75
BAJE
-2.34%
1,030.20
ADNA
-1.90%
1,035.10
NATP
+0.23%
525.35
VIML
+12.75%

FAQ

What Stock Exchange Does Jagsonpal Pharmaceuticals Trade On?

Jagsonpal Pharmaceuticals is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Jagsonpal Pharmaceuticals?

The stock symbol for Jagsonpal Pharmaceuticals is "JGSN."

What Is the Jagsonpal Pharmaceuticals Market Cap?

As of today, Jagsonpal Pharmaceuticals market cap is 16.91B.

What Is Jagsonpal Pharmaceuticals's Earnings Per Share (TTM)?

The Jagsonpal Pharmaceuticals EPS (TTM) is 8.26.

From a Technical Analysis Perspective, Is JGSN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Jagsonpal Pharmaceuticals Stock Split?

Jagsonpal Pharmaceuticals has split 1 times.

How Many Employees Does Jagsonpal Pharmaceuticals Have?

Jagsonpal Pharmaceuticals has 1025 employees.

What is the current trading status of Jagsonpal Pharmaceuticals (JGSN)?

As of 18 Jul 2025, Jagsonpal Pharmaceuticals (JGSN) is trading at a price of 254.20, with a previous close of 252.43. The stock has fluctuated within a day range of 248.86 to 257.76, while its 52-week range spans from 133.60 to 328.04.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.